The INK4a/ARF locus on chromosome 9p21, which encodes two distinct genes, p14 ARF Renal cell carcinoma (RCC), the most common malignancy of the adult kidney, occurs in sporadic and hereditary forms. Recent studies characterizing genetic aberrations have implicated a number of chromosomal loci in cancer development and progression, with inactivation of tumor suppressor genes as one of the most important steps. Chromosome 3p deletions constitute the most common genetic event in primary RCCs and aberration of the VHL gene at 3p25 is known to occur early in the genesis of clear cell lesions.
Renal cell carcinoma (RCC), the most common malignancy of the adult kidney, occurs in sporadic and hereditary forms. Recent studies characterizing genetic aberrations have implicated a number of chromosomal loci in cancer development and progression, with inactivation of tumor suppressor genes as one of the most important steps. Chromosome 3p deletions constitute the most common genetic event in primary RCCs and aberration of the VHL gene at 3p25 is known to occur early in the genesis of clear cell lesions. 1, 2) However, chromosome 3p is not cytogenetically aberrant in papillary RCCs and adult rather than in childhood tumors, even among individuals who inherit a mutated VHL gene. The RCC is also characterized by an accumulation of complex chromosomal alterations during tumor progression with loss of heterozygosity (LOH) relatively frequently observed for chromosomes 6q, 8p, 9p, 13q and 17p. 3, 4) Loss of the short arm of chromosome 9, in particular 9p21-22, is common in many human neoplasms, for example melanomas, 5) bladder tumors, 6) and leukemia. 7) Furthermore, the p16 INK4a gene isolated from 9p21 has been found to be homozygously deleted in many types of tumor cell lines, including examples derived from RCCs. 8) In human neoplasms, loss of p16
INK4a expression is mainly due to homozygous deletion or to hypermethylation of CpG islands in the promoter region, while mutational inactivation is rare. 9) In primary RCCs, LOH on chromosome 9p has been detected in 20-30% of cases, 10, 11) but inactivation of p16 INK4a by homozygous deletion or point mutation is rare. [12] [13] [14] Recently, the p14 ARF gene was isolated as a second alternative reading frame gene of p16
INK4a of the INK4a locus and the human p14 ARF promoter has been cloned and shown to contain a CpG island.
15) The INK4a locus features two unique first exons, designated 1α and 1β, which are spliced into common exons 2 and 3.
16) Exons 1α, 2 and 3 encode p16 INK4a which induces cell cycle arrest by inhibiting phosphorylation of the RB protein.
17) The product of exons 1β, 2 and 3 is termed p14 ARF , which acts by binding directly to MDM2, resulting in the stabilization of both p53 and MDM2. 18, 19) Despite the potential importance of p14 ARF and p16 INK4a in tumorigenesis, there have been few studies of inactivation by homozygous deletions or altered methylation in primary RCCs.
To investigate whether the INK4a/ARF locus on chromosome 9 is involved in renal cell tumorigenesis, we screened 91 primary RCCs and 6 cell lines for homozygous deletion, promoter hypermethylation of the p14 ARF and p16
INK4a genes and expression of the gene products. Six human RCC cell lines (SKRC-12, -14, -17,  -29 , -52, and -59) were cultured in RPMI 1640 (Gibco, Gaithersburg, MD) supplemented with 10% fetal calf serum. 20) Genomic DNA was extracted from each cell line as described previously. 21) Adherent cells were harvested by trypsinization, collected by centrifugation for 5 min at 1500 rpm and pellets of cells were fixed in 10% buffered formalin and embedded in paraffin. 5 To whom correspondence and requests for reprints should be addressed.
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Tumor samples and DNA extraction Ninety-one primary tumor specimens were obtained from patients who had undergone nephrectomy between 1995 and 2000 in the Department of Urology, Nara Medical University Hospital and Nara Prefectural Hospital. Tumors were fixed in 10% buffered formalin, embedded in paraffin and sectioned at 3 µm. The sections were stained with hematoxylin and eosin for histological diagnosis. Pathological evaluation and grading were according to the classification by the UICC and the AJCC. 22, 23) Under a light microscopy, tumor lesions were marked and scraped off. Genomic DNA was extracted from each section as described previously. 24) Differential PCR assay for p14 ARF and p16
INK4a
To assess homozygous deletions in the p14 ARF gene, we carried out differential PCR with primers for exon 1β, using the GAPDH gene as an internal control. The primer sequences and PCR conditions were as described previously 25) and the lengths of PCR products for p14 ARF and GAPDH were 149 bp and 160 bp, respectively.
Differential PCR for homozygous deletions of p16
(exon 1) was carried out using the β-actin gene as an internal control. The primer sequences and PCR conditions were as previously described. 25, 26) The lengths of PCR products for p16
INK4a and β-actin were 204 bp and 187 bp, respectively. They were loaded onto 8% acrylamide gels and signal intensity was measured with Kodak Digital Science ID Image Analysis Software Version 3.0 (Kodak, NY). Values less than 0.2 for the target gene/ internal control ratio were considered to represent homozygous deletion. [25] [26] [27] [28] Methylation-specific PCR Promoter hypermethylation of the p14 ARF and p16 INK4a genes was determined by methylation-specific PCR (MSP), 29) which distinguishes unmethylated from methylated alleles based on sequence changes produced after bisulfite conversion of unmethylated (but not methylated) cytosines to uracil, and subsequent PCR using primers designed for either methylated or unmethylated DNA. Sodium bisulfite modification was performed using a "CpGenome" DNA Modification Kit (Intergen, Oxford, UK) according to the manufacturer's protocol with minor modifications. 25, 30) Primer sequences for the methylated and unmethylated PCR of p14 ARF were as previously reported by Esteller et al., 31) and those for p16 INK4a were reported by Herman et al. 29) PCR was carried out in a 10 µl mixture containing 1× PCR buffer (10 mM Tris pH 8.3, 50 mM KCl), 2 mM MgCl 2 , 0.25 mM deoxyribonucleotide triphosphates 25, 29, 31) Amplified products were electrophoresed on 2% agarose gels, and were visualized by ethidium bromide staining. 25) 
p14
ARF and p16 INK4a immunohistochemistry After deparaffinization, sections were heated for 5 min at 120°C in an autoclave in 10 mM sodium citrate buffer (pH 6.0). For p14 ARF immunohistochemistry, the sections were incubated overnight at 4°C with rabbit polyclonal antibody 14 ARF (SC-8348, Santa Cruz Biotechnology, Inc., Santa Cruz, CA) at 1:400 dilution. For p16
INK4a immunohistochemistry, sections were incubated for 1 h at room temperature with a mouse monoclonal antibody (SC1661, Santa Cruz Biotechnology, Inc.) at 1:500 dilution. The reactions were visualized using a Histofine SAB-PO Kit (Nichirei Corp., Tokyo) and diaminobenzidine, and sections were counterstained with hematoxylin. The percentage of neoplastic cells with nuclear immunoreactivity was recorded as negative (−) when only occasional (<10%) tumor cells were stained and positive (+) when over 10% of the tumor cells were stained. (Table III) . Three samples with homozygous deletion showed defective immunoreactivity, although one sample with promoter hypermethylation showed expression of p14 ARF and p16 INK4a (Fig. 3) . Aberrations of p14 ARF or p16 INK4a were detected in eight of 91 (8.8%) samples by one or more of the three methods. There was no significant correlation with histological findings, tumor size or grading. However, six of the 8 cases featured gross extension into the renal vein (Table III) .
32)
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DISCUSSION
The chromosome 9p21 region harbors two genes: p14 ARF and p16
INK4a
, whose products have growth-suppressive activity. Two primary mechanisms have been postulated for inactivation of potential tumor suppressor genes on 9p21: homozygous deletion and promoter hypermethylation, with intragenic mutations occurring in only a small proportion of tumors and cell lines. 33) The present results showed aberration of p14 ARF and p16 INK4a due to homozygous deletion and promoter hypermethylation to be more frequent in RCC cell lines than in primary RCCs, suggesting that the alterations might provide some advantage associated with acquisition of immortality and selective cell growth.
Homozygous deletion of the p16 INK4a gene has been demonstrated frequently in cell lines derived from a variety of different tumors, 34, 35) and therefore, p16 INK4a is widely regarded as a major target with 9p21 deletion. A previous study showed inactivation of p16
INK4a by homozygous deletion to be relatively rare in RCCs, 13) and the type alteration of p14 ARF and p16 INK4a was detected in only three of 91 (3.3%) primary RCCs in our study. To assess the sensitivity of differential PCR for p14 ARF and p16 INK4a deletion, we previously carried out a titration experiment with various ratios of normal DNA and DNA from A172 
Gross extension into the renal vein. INK4a genes. 25) The results indicated that the ratios of p14 ARF /GAPDH and p16 INK4a /β-actin meaning hemizygous deletion are ~0. 42 36) or ARF alone. 37) In mice, malignant transformation is induced by inactivation of either the p53 pathway or the RB pathway, and the p14 ARF and p16 INK4a genes are frequently co-deleted in several human neoplasms, 38, 39) with inactivation of both having a cooperative negative effect on tumor progression. [40] [41] [42] 10, 11) suggesting a contribution to tumor progression. Recent studies showed that loss of chromosome 9p13 is associated with progression in papillary RCCs, so that a tumor suppressor gene on chromosome 9p13 may play a role. 44, 45) In our study, eight cases (8.8%) demonstrated p14 ARF and p16 INK4a aberration. Although there was no significant correlation between aberration and histological types, tumor size, or grading, six of these cases (75%) showed gross extension into the renal vein (Table III) . Therefore, aberrations such as deletion, methylation and loss of expression of p14 ARF and p16
INK4a may be associated with tumor extension into the renal vein. Venous invasion is characterized by local destruction of the endothelium by tumors. In a cohort study of RCC, patients with venous invasion were found to have a worse prognosis.
In summary, aberrations of p14 ARF and p16 INK4a such as homozygous deletions and hypermethylation were detected in a small subset of primary RCCs. Although a relatively rare event, such alteration appeared to be associated with tumor extension into the renal vein. Our results thus suggest the p14 ARF and p16 INK4a genes to be important with regard to 9p deletion, having a possible role in primary RCC progression.
